A carregar...
Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients wi...
Na minha lista:
| Publicado no: | Am J Cardiovasc Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7152511/ https://ncbi.nlm.nih.gov/pubmed/32281055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-020-00406-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|